Director – IT Infrastructure and Security
MBX Biosciences
Director – IT Infrastructure and Security
MBX Biosciences
Develops peptide-based therapies for endocrine diseases
Working with Us
MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides.
Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential.
Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform.
If you’re passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn.
What You will Do
The Director, IT Infrastructure and Security, is a hands-on leader responsible for the reliability, security and scalability of the technology environment that supports MBX Biosciences as we advance our pipeline toward late-stage development. Reporting to the VP, IT, you will build and scale IT operations in a regulated environment, own the operational execution of our cybersecurity program in partnership with our fractional CISO, and help lead the security strategy and policy, and oversee cloud, network and Tier 1 and Tier 2 service desk operations. You will be well versed in modern advanced technologies, including generative and agentic AI, and will use them to strengthen security operations, improve insight into risk, and increase the efficiency of IT. This role combines strategic leadership with direct technical involvement and is ideal for someone who is equally comfortable setting direction with executives and rolling up their sleeves to solve problems alongside the team.
Key responsibilities include:
What You Bring
Travel & In Office Presence
You will be expected to travel periodically based on the needs of the business, including attendance at Together Weeks, Together Days, and functional meetings as requested by the team. Employees are expected to work on hybrid schedules, consistent with local office practices and the terms of the companies in office policy as in effect from time to time.
EEO Statement:
MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.
Develops peptide-based therapies for endocrine diseases
MBX Biosciences discovers and develops peptide-based therapies for endocrine and metabolic diseases. Its work centers on the Precision Endocrine Peptide (PEP) platform, which helps create novel peptide drug candidates that target endocrine pathways. The company advances these candidates through clinical trials to establish safety and efficacy, seeking regulatory approval and potential partnerships for commercialization. MBX differentiates itself with a proprietary peptide platform focused on gap areas in endocrine/metabolic medicine, moving programs in a clinical-stage biopharmaceutical model that relies on capital from investors until products reach the market. Its goal is to bring approved therapies to patients with unmet medical needs in endocrine and metabolic disorders through partnerships or licensing with larger pharma players when appropriate.
Explore more opportunities at MBX Biosciences